Nimbolide is an Anticancer Agent for Triple-negative Breast Cancer Research
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. It accounts for approximately...
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. It accounts for approximately...
Estrogen is a critical steroid in human physiology, the female sex hormone, exerts anti-inflammatory and...
On November 16, 2023, the Food and Drug Administration approved Capivasertib with Fulvestrant for adult...
Amcenestrant is an orally active, nonsteroidal and selective estrogen receptor degrader (SERD) for breast cancer research.
Metabotropic glutamate (mGlu) receptors are G protein-coupled receptors (GPCRs) which act predominantly as modulators of...
CDKs (Cyclin-dependent kinases) are serine-threonine kinases first discovered for their role in regulating the cell...
Breast cancer is the most common cancer in women all over the world. Breast cancer...
HDACs (Histone deacetylases) are a class of enzymes that remove acetyl groups (O=C-CH3) from an...
Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) play a crucial role in angiogenesis...
Breast cancer is the most common malignancy in women, and one of the three most...